Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-17A: Possible mediator and therapeutic target in hypertension.
Rodrigues-Diez RR, Tejera-Muñoz A, Orejudo M, Marquez-Exposito L, Santos L, Rayego-Mateos S, Cantero-Navarro E, Tejedor-Santamaria L, Marchant V, Ortiz A, Egido J, Mezzano S, Selgas R, Navarro-González JF, Valdivielso JM, Lavoz C, Ruiz-Ortega M. Rodrigues-Diez RR, et al. Among authors: valdivielso jm. Nefrologia (Engl Ed). 2021 May-Jun;41(3):244-257. doi: 10.1016/j.nefro.2020.11.009. Epub 2021 Mar 26. Nefrologia (Engl Ed). 2021. PMID: 33775443 Free article. Review. English, Spanish.
Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
Sanchez-Niño MD, Bozic M, Córdoba-Lanús E, Valcheva P, Gracia O, Ibarz M, Fernandez E, Navarro-Gonzalez JF, Ortiz A, Valdivielso JM. Sanchez-Niño MD, et al. Among authors: valdivielso jm. Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F647-57. doi: 10.1152/ajprenal.00090.2011. Epub 2011 Dec 14. Am J Physiol Renal Physiol. 2012. PMID: 22169009 Free article.
Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease.
Barrios C, Pascual J, Otero S, Soler MJ, Rodríguez E, Collado S, Faura A, Mojal S, Navarro-González JF, Betriu A, Fernandez E, Valdivielso JM; investigators of the NEFRONA study. Barrios C, et al. Among authors: valdivielso jm. Atherosclerosis. 2015 Sep;242(1):37-44. doi: 10.1016/j.atherosclerosis.2015.06.048. Epub 2015 Jun 30. Atherosclerosis. 2015. PMID: 26177272
Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
Fernández-Laso V, Sastre C, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM. Fernández-Laso V, et al. Among authors: valdivielso jm. Clin J Am Soc Nephrol. 2016 Mar 7;11(3):413-22. doi: 10.2215/CJN.07900715. Epub 2016 Jan 4. Clin J Am Soc Nephrol. 2016. PMID: 26728587 Free PMC article.
Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.
Fernández-Laso V, Méndez-Barbero N, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM. Fernández-Laso V, et al. Among authors: valdivielso jm. Atherosclerosis. 2017 May;260:130-137. doi: 10.1016/j.atherosclerosis.2017.03.043. Epub 2017 Mar 31. Atherosclerosis. 2017. PMID: 28390291
Beyond the traditional lipid parameters in chronic kidney disease.
Bermúdez-López M, Betriu À, Valdivielso JM, Bretones Del Pino T, Arroyo D, Fernández E. Bermúdez-López M, et al. Among authors: valdivielso jm. Nefrologia (Engl Ed). 2018 Mar-Apr;38(2):109-113. doi: 10.1016/j.nefro.2017.09.008. Epub 2017 Nov 11. Nefrologia (Engl Ed). 2018. PMID: 29137894 Free article. English, Spanish. No abstract available.
185 results